Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Aethlon Medical (AEMD) over the last 15 years, with Q1 2025 value amounting to $304795.0.

  • Aethlon Medical's Other Working Capital Changes rose 423.05% to $304795.0 in Q1 2025 from the same period last year, while for Mar 2025 it was -$113923.0, marking a year-over-year decrease of 121339.91%. This contributed to the annual value of -$113923.0 for FY2025, which is 121339.91% down from last year.
  • As of Q1 2025, Aethlon Medical's Other Working Capital Changes stood at $304795.0, which was up 423.05% from -$126647.0 recorded in Q4 2024.
  • Aethlon Medical's Other Working Capital Changes' 5-year high stood at $441413.0 during Q4 2021, with a 5-year trough of -$513343.0 in Q4 2022.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$40781.0 (2023), whereas its average is $23534.1.
  • Per our database at Business Quant, Aethlon Medical's Other Working Capital Changes surged by 643824.5% in 2022 and then plummeted by 22747.96% in 2023.
  • Aethlon Medical's Other Working Capital Changes (Quarter) stood at $441413.0 in 2021, then crashed by 216.3% to -$513343.0 in 2022, then soared by 92.06% to -$40781.0 in 2023, then tumbled by 210.55% to -$126647.0 in 2024, then skyrocketed by 340.66% to $304795.0 in 2025.
  • Its Other Working Capital Changes was $304795.0 in Q1 2025, compared to -$126647.0 in Q4 2024 and -$202199.0 in Q3 2024.